---
title: "Maccura's multiple projects selected for the Sichuan Province Innovative Medical Device Integration Application Pilot"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/241337669.md"
description: "According to maccura, recently, the four major projects of fully automatic biochemical analyzers, chemiluminescence immunoassay analyzers, sample processing systems, and coagulation analyzers declared by maccura have successfully been selected as pilot projects for the integration and application of innovative medical devices in Sichuan Province"
datetime: "2025-05-22T02:40:42.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/241337669.md)
  - [en](https://longbridge.com/en/news/241337669.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/241337669.md)
generator: "portal-rs"
---

# Maccura's multiple projects selected for the Sichuan Province Innovative Medical Device Integration Application Pilot

According to maccura, recently, the four major projects of fully automatic biochemical analyzers, chemiluminescence immunoassay analyzers, sample processing systems, and coagulation analyzers declared by maccura have successfully been selected for the Sichuan Province Innovative Medical Device Integration Application Pilot

### Related Stocks

- [300463.CN](https://longbridge.com/en/quote/300463.CN.md)

## Related News & Research

- [Guangdong Dtech shareholders to vote Sept. 15 on ending Rongcheng Hong Kong auditor engagement](https://longbridge.com/en/news/296359557.md)
- [Orkla Non-GAAP EPS of NOK 1.60, revenue of NOK 16.7B](https://longbridge.com/en/news/296456178.md)
- [CARsgen FY26 H1 net loss narrows to RMB 70.84 million; revenue rises 21.49% to RMB 61.92 million](https://longbridge.com/en/news/296243257.md)
- [Aditya Birla Capital gains 2.5% after gold loan entry, plans 1,000 branches](https://longbridge.com/en/news/296432637.md)
- [Kona BidCo raises Zalaris stake to 87.34% after buying 2,337 shares at NOK 100 apiece](https://longbridge.com/en/news/296256150.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**